Noetik CEO and co-founder Ron Alfa, M.D., Ph.D., said the licensing of human foundation models is “a new paradigm in biotech.” With the GSK deal validating the paradigm, in Alfa’s view, Noetik ...

GSK noted recent deals as source of fresh revenues amid patent expiries and an AI-driven boost to drug discovery.

Ideally, by the time the press gets their hands on a new product or service, all the kinks have already been worked out. Not so for “Claudius,” an AI-operated vending machine that Anthropic lent to ...

Add articles to your saved list and come back to them any time. You can complain about progress, you can fight it, but you can’t beat it, so you might as well join it. As Pat Cummins’ Australians ...

Canadian computer scientist Yoshua Bengio warns against granting legal rights to cutting-edge technology A pioneer of AI has criticised calls to grant the technology rights, warning that it was ...

For much of its history, corporate automation adoption has been a slow, incremental process. That steady march is now poised to become a transformative leap. We are at the inflection point when the ...